SCHEMBL8059273

SCHEMBL8059273

O=C(O)C(Cc1cccs1)(c1ccccc1)[PH](=O)O

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.41
HPGD P15428 3/20 0.40
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
RAB9A P51151 1/20 0.38
POLB P06746 3/20 0.37
TDP1 Q9NUW8 1/20 0.37
KMT2A Q03164 2/20 0.36
PKM P14618 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP2C9 P11712 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
USP2 O75604 1/20 0.35
TSHR P16473 1/20 0.35
SLC1A3 P43003 1/20 0.35
SLC1A2 P43004 1/20 0.35
SLC1A1 P43005 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8058494 0.86 CYP2C19 (0.40) CYP2C19HPGDLMNASMN1; SMN2RAB9A
SCHEMBL8058563 0.75 GRM2 (0.39) SMN1; SMN2POLBTDP1SLC1A3SLC1A2
SCHEMBL8046670 0.75 KCNA5 (0.39) CYP2C19HPGDSMN1; SMN2KMT2AALDH1A1
SCHEMBL28823525 0.74 CYP2C19 (0.45) CYP2C19HPGDLMNASMN1; SMN2RAB9A
SCHEMBL28997198 0.72 CYP2C19 (0.53) CYP2C19HPGDLMNASMN1; SMN2RAB9A
SCHEMBL28013234 0.72 RIPK1 (0.43) CYP2C19HPGDLMNASMN1; SMN2RAB9A
SCHEMBL27569205 0.71 POLB (0.46) CYP2C19HPGDLMNASMN1; SMN2RAB9A
SCHEMBL27988728 0.71 CYP2C19 (0.52) CYP2C19HPGDLMNASMN1; SMN2RAB9A
SCHEMBL27480004 0.71 CYP2C19 (0.52) CYP2C19HPGDLMNASMN1; SMN2RAB9A
SCHEMBL8057354 0.71 FDPS (0.44) CYP2C19HPGDLMNASMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6046180-A NAALADase inhibitors GUILFORD PHARMACEUTICALS INC. (US) 2000-04-04 US disclosed
EP-0936914-A1 HYDROXY-PHOSPHINYL DERIVATIVES USEFUL AS NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1999-08-25 EP disclosed
EP-0936914-A4 1999-08-25 EP disclosed
WO-1997048400-A1 HYDROXY-PHOSPHINYL DERIVATIVES USEFUL AS NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1997-12-24 WO disclosed